#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA4419253	A	Terminal half life in iv dosed mouse	Mus musculus	12	ALA4419164	organism-based format	Patent Bioactivity Data
2.	ALA4419254	B	Binding affinity to CNKSR1 PH-domain (unknown origin) by SPR spectroscopy	Homo sapiens	46	ALA4419164	single protein format	Patent Bioactivity Data
3.	ALA4419259	B	Binding affinity to AKT PH-domain (unknown origin) at 0.01 to 50 uM by SPR spectroscopy	Homo sapiens	37	ALA4419164	single protein format	Patent Bioactivity Data
4.	ALA4419273	F	Growth inhibition of human NCI-H1975 cells incubated for 3 days	Homo sapiens	35	ALA4419164	cell-based format	Patent Bioactivity Data
5.	ALA4419274	F	Growth inhibition of human NCI-H226 cells incubated for 3 days	Homo sapiens	35	ALA4419164	cell-based format	Patent Bioactivity Data
6.	ALA4419275	F	Growth inhibition of human HCC95 cells incubated for 3 days	Homo sapiens	6	ALA4419164	cell-based format	Patent Bioactivity Data
7.	ALA4419276	F	Growth inhibition of human H1375 cells incubated for 3 days	Homo sapiens	6	ALA4419164	assay format	Patent Bioactivity Data
8.	ALA4419277	F	Growth inhibition of human NCI-H2122 cells incubated for 3 days	Homo sapiens	6	ALA4419164	cell-based format	Patent Bioactivity Data
9.	ALA4419278	F	Growth inhibition of human HCC515 cells incubated for 3 days	Homo sapiens	6	ALA4419164	cell-based format	Patent Bioactivity Data
10.	ALA4419285	A	Clearance in iv dosed mouse	Mus musculus	11	ALA4419164	organism-based format	Patent Bioactivity Data
11.	ALA4419294	B	Inhibition of CNKSR1 (unknown origin) assessed as reduction in inhibition of KRas signaling effectors by measuring p-AKT levels at 20 uM by cell based assay	Homo sapiens	5	ALA4419164	cell-based format	Patent Bioactivity Data
12.	ALA4419295	B	Inhibition of CNKSR1 (unknown origin) assessed as reduction in inhibition of KRas signaling effectors by measuring p-MAPK levels at 20 uM by cell based assay	Homo sapiens	5	ALA4419164	cell-based format	Patent Bioactivity Data
13.	ALA4419296	B	Inhibition of CNKSR1 (unknown origin) assessed as reduction in inhibition of KRas signaling effectors by measuring GTP-RalA levels at 20 uM by cell based assay	Homo sapiens	5	ALA4419164	cell-based format	Patent Bioactivity Data